Even still, large gaps remain. Every day, 3,000 children die from malaria. About 100,000 children die from HIV-related causes each year. These are diseases that are entirely preventable and treatable. Malaria is controlled with mosquito bed nets, antimalarial treatment courses, and insecticides. Antiretroviral treatments are making it possible for people living with HIV to live a long, healthy life.
If solutions exist, then why do we continue to see such levels of morbidity and mortality in the developing world? Too often it comes down to a lack of the right tools in the right place and at the right time. In seventeen malaria endemic countries in Africa, for example, indoor residual spraying (IRS) is used at a cost of hundreds of millions of dollars per year to kill mosquito vectors of malaria. In many cases, this tool is not achieving its full potential of reducing malaria, in part because it is not distributed to obtain a high enough true coverage. The World Health Organization tells us that IRS must be applied to at least 85% of a community in order to reach “true” coverage. Given the costs and the lack of enough resources to go around, the impact of this intervention sways further away from optimally saving lives from malaria.